Variants may reduce the amount of functional FOXC1 that is produced or affect the DNA binding capability of FOXC1, resulting in functional haploinsufficiency, leading to variable ASD in humans and mice [18,19]. The gene discussed is FOXC1; the disease is atrial septal defect.